| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA5291235
Max Phase: Preclinical
Molecular Formula: C18H15NO6
Molecular Weight: 341.32
Associated Items:
Representations
Canonical SMILES: CC(=O)c1c(O)c(C)c(O)c2c1OC1=Cc3onc(C)c3C(=O)[C@@]12C
Standard InChI: InChI=1S/C18H15NO6/c1-6-14(21)12(8(3)20)16-13(15(6)22)18(4)10(24-16)5-9-11(17(18)23)7(2)19-25-9/h5,21-22H,1-4H3/t18-/m0/s1
Standard InChI Key: PYCLUZIYUBSSGD-SFHVURJKSA-N
Associated Targets(Human)
HeLa (62764 Activities)
CYP2C8 Tchem Cytochrome P450 2C8 (1492 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
CYP2C19 Tchem Cytochrome P450 2C19 (29246 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
CYP3A4 Tclin Cytochrome P450 3A (122 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 341.32 | Molecular Weight (Monoisotopic): 341.0899 | AlogP: 2.79 | #Rotatable Bonds: 1 |
| Polar Surface Area: 109.86 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 2 |
| #RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 7.53 | CX Basic pKa: 0.35 | CX LogP: 1.92 | CX LogD: 1.68 |
| Aromatic Rings: 2 | Heavy Atoms: 25 | QED Weighted: 0.77 | Np Likeness Score: 1.27 |
References
| 1. Gunawan GA, Gimła M, Gardiner MG, Herman-Antosiewicz A, Reekie TA.. (2023) Divergent reactivity of usnic acid and evaluation of its derivatives for antiproliferative activity against cancer cells., 79 [PMID:36652792] [10.1016/j.bmc.2023.117157] |
Source
Source(1):